Already active in the country through its subsidiaries Alta Genetics, Genex, Transov, and Vas, the American company now plans to bring all other bovine genetics firms in its portfolio to Brazil
04/17/2025
Already active in Brazil through subsidiaries Alta Genetics, Genex, Transova, and Vas, U.S.-based Urus has announced it will begin full-scale operations in the country starting in June. With the expansion, the company will introduce all other bovine genetics businesses in its global portfolio to the Brazilian market, bringing the group’s total operations in the country to eleven.
“This study has been underway for the past two years, with the companies entering individually. Now, they’ll be integrated, and we’ll undoubtedly offer a much stronger solution to the market,” said Heverardo Carvalho, current director of Alta Brasil.
As of June, Mr. Carvalho will step into the role of director of Urus, while Tiago Carrara, currently Alta’s market manager, will assume leadership of Alta Brasil. “Our goal is to work together more efficiently to deliver more consistent results for our clients,” said Mr. Carrara.
With the expanded presence of its parent company, Alta expects to grow 15% in 2025, compared to 8% in 2024. Genex, meanwhile, is forecasting 17% growth this year, up from 15% in 2023.
The group does not disclose revenue figures but reports that Alta and Genex currently account for roughly 45% of Brazil’s bovine genetics market.
“We anticipate double-digit growth over the next two to three years, capitalizing on the upward cycle in cattle breeding,” said Sergio Saud, Genex’s sales leader.
To support the arrival of additional brands, the group will invest R$10 million in a new distribution center in Uberaba (MG). Among the new additions to the Brazilian market will be Genetics Australia—acquired by the group last year—which specializes in tropical livestock.
Other brands in the portfolio include PEAK, a global leader in bull production for genetics centers; SCCL, which converts bovine colostrum into biological products for calf health; and Jetstream Genetics, known for premium Holstein and Jersey dairy cattle.
“Expanding our portfolio will become a much stronger reality from now on, and that’s exactly why we’ll need a more robust structure,” said Mr. Carvalho.
*By Cleyton Vilarino — São Paulo
Source: Valor International